Does Aetna Cover Lantus?
The verdict
Covered on most plans
Aetna covers Lantus (insulin glargine) for type 1 and type 2 diabetes management across commercial, ACA, Medicare, and Medicaid, managed through CVS Caremark. The dominant cost fact is the $35/month insulin cap: on Medicare Part D, the IRA mandates that any covered insulin costs no more than $35/month and the deductible is waived. Sanofi also caps commercial out-of-pocket at $35 following its 2024 list-price reduction. Some Caremark plans may prefer a biosimilar (Semglee or Rezvoglar) — verify on the Aetna/Caremark formulary.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Aetna using your member ID.
Medicare vs. commercial coverage
Whether Aetna covers Lantus depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Lantus is covered on most Aetna Medicare Part D plans (Lantus is covered by approximately 70% of Medicare plans, per SingleCare). The governing cost rule is the IRA insulin cap: all covered insulins, including Lantus, cost no more than $35/month on Medicare Part D, with the deductible waived. For 2026, CMS has codified this as the lesser of $35, 25% of the Maximum Fair Price, or 25% of the negotiated price. Lantus is not subject to an IRA negotiated Maximum Fair Price — the $35 insulin cap is the cost anchor, not an MFP. Medicare beneficiaries cannot use Sanofi's commercial savings programs. Verify Lantus is covered on your specific Aetna Medicare Part D plan.
Commercial / Employer
Group & marketplace plans
Covered via CVS Caremark across Aetna commercial/employer and ACA plans. Tier placement varies (some plans Tier 3); Sanofi cut Lantus's list price 78% (effective 2024) and caps commercial out-of-pocket at $35/month through its Sanofi Copay Program. Some Caremark commercial plans prefer biosimilar insulin glargine (Semglee, Rezvoglar) as a lower-cost formulary option — verify whether Lantus or a biosimilar is preferred on your specific Aetna plan. Medicaid: covered per state preferred drug list; nominal cost-share ($0–$3 typical); a biosimilar may be the preferred Medicaid insulin in some states.
Your cost, three ways
What Lantus actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$84–$104 per pen (pharmacy-variable estimate, SoloStar pen, cash price)
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Part D: $35/month cap, deductible waived (IRA insulin cap); commercial: Sanofi caps OOP at $35/month (Sanofi Copay Program, commercially insured only)
Typical monthly copay once prior authorization is approved.
Bridge program
Sanofi Insulins Valyou Savings Program / Sanofi Copay Program — $35/month OOP cap for commercially insured patients; Sanofi also cut Lantus list price 78% (effective 2024)
Reduced copay through the assistance program, where eligible.
No IRA Maximum Fair Price applies to Lantus — the $35/month Medicare insulin cap (deductible waived) is the cost anchor. Commercial cost governed by Sanofi's $35 OOP cap and the CVS Caremark tier. All figures are estimates — verify with Aetna Member Services or the Caremark formulary.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Check whether Lantus or a biosimilar is preferred on your Caremark plan
Log in to the Aetna member portal (aetna.com) or CVS Caremark (caremark.com) and search for Lantus (insulin glargine). Check whether Lantus is a preferred brand or whether a biosimilar (Semglee or Rezvoglar) is listed on a lower tier. If Lantus is non-preferred, ask your physician whether a biosimilar is clinically appropriate or whether a non-preferred exception applies.
- 2
Confirm the $35 insulin cap for Medicare or the Sanofi savings program for commercial
If you have Aetna Medicare Part D, confirm with the pharmacy at fill time that the $35/month insulin cap applies and the deductible is waived — this is mandatory under the IRA for all covered Part D insulins. If you have Aetna commercial coverage, ask your pharmacist to apply the Sanofi Copay Program (which caps your OOP at $35/month).
- 3
Call Aetna Member Services or Sanofi for savings program details
Call the pharmacy benefits number on your Aetna ID card to confirm Lantus coverage, tier, and cost-share. For commercial patients, contact Sanofi at 1-888-847-4877 or visit insulinhelp.sanofi.com to enroll in the commercial copay program if needed.
Options if Aetna won't cover Lantus
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Semglee (insulin glargine-yfgn) — biosimilar
FDA-approved biosimilar to Lantus (same active ingredient, insulin glargine). Some Aetna/Caremark plans list Semglee on a lower tier than branded Lantus. Medicare $35/month cap applies to Semglee as well. Ask your physician if switching is clinically appropriate.
Rezvoglar (insulin glargine-aglr) — biosimilar
Another FDA-approved Lantus biosimilar. May be preferred on some Caremark commercial and Medicaid plans. Subject to the Medicare $35/month insulin cap if covered on your Part D plan.
Basaglar (insulin glargine-yfgn) — biosimilar
Another long-acting insulin glargine biosimilar available as an alternative to Lantus. Check Aetna/Caremark formulary for preferred tier placement.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
On Aetna Medicare Part D, the IRA insulin cap limits your Lantus cost to $35/month, with the deductible waived. For 2026, CMS has codified this as the lesser of $35, 25% of the Maximum Fair Price, or 25% of the negotiated price — in practice, $35 or less per month. This cap applies regardless of which tier Lantus falls on in your Aetna Part D plan. Verify that Lantus is covered on your specific plan, as approximately 70% of Medicare Part D plans cover it.
Yes — Aetna commercial and ACA plans cover Lantus via CVS Caremark, though tier placement varies. Sanofi cut Lantus's list price 78% (effective 2024) and offers a copay program capping commercial OOP at $35/month. Some Caremark plans may list a biosimilar (Semglee or Rezvoglar) as preferred. Verify your specific plan tier on the Caremark formulary and ask your pharmacist to apply the Sanofi Copay Program if you are commercially insured.
Semglee (insulin glargine-yfgn) and Rezvoglar (insulin glargine-aglr) are FDA-approved biosimilars to Lantus. Some Aetna/CVS Caremark plans list them on a lower tier than branded Lantus. They contain the same active ingredient (insulin glargine) and have the same clinical indication. The Medicare $35/month insulin cap applies to covered biosimilar insulins as well. Ask your physician whether switching to a biosimilar is clinically appropriate for your regimen.
No — Lantus is not one of the drugs subject to the IRA's direct price negotiation Maximum Fair Price program (which covers drugs like Jardiance at $197 and Eliquis at $231). Lantus's Medicare cost is instead governed by the separate IRA insulin cap: $35/month with deductible waived, for all covered Part D insulins. Sanofi voluntarily cut Lantus's list price 78% (effective 2024) for commercial markets. These are two different cost mechanisms.
Generally no — prior authorization is not typically required for a preferred basal insulin like Lantus. However, some Aetna/CVS Caremark plans list a biosimilar (Semglee or Rezvoglar) as the preferred formulary insulin and may require a non-preferred brand exception to use Lantus specifically. This is a step-toward-biosimilar preference, not a clinical PA. Verify on the Caremark formulary whether Lantus is preferred or whether a biosimilar is the plan's first choice.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Aetna before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.